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Atmany central synapses, endocannabinoids released by postsynaptic cells act retrogradely on presynaptic G-protein-coupled cannabi-
noid receptors to inhibit neurotransmitter release. Here, we demonstrate that cannabinoids may directly affect the functioning of
inhibitory glycine receptor (GlyR) channels. In isolated hippocampal pyramidal and Purkinje cerebellar neurons, endogenous cannabi-
noids anandamideand2-arachidonylglycerol, appliedatphysiological concentrations, inhibited the amplitudeandaltered thekinetics of
rise time, desensitization, and deactivation of the glycine-activated current (IGly ) in a concentration-dependentmanner. These effects of
cannabinoids were observed in the presence of cannabinoid CB1/CB3, vanilloid receptor 1 antagonists, and the G-protein inhibitor
GDPS, suggesting a direct action of cannabinoids on GlyRs. The effect of cannabinoids on IGly desensitization was strongly voltage
dependent. We also demonstrate that, in the presence of a GABAA receptor antagonist, GlyRs may contribute to the generation of
seizure-like activity induced by short bursts (seven stimuli) of high-frequency stimulation of inputs to hippocampal CA1 region, because
this activitywas diminishedby selectiveGlyR antagonists (strychnine and ginkgolidesB and J). TheGlyR-mediated rhythmic activitywas
also reduced by cannabinoids (anandamide) in the presence of a CB1 receptor antagonist. These results suggest that the direct inhibition
of GlyRs by endocannabinoids can modulate the hippocampal network activity.
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Introduction
Cannabinoids influence brain function primarily by activating
the G-protein-coupled cannabinoid CB1 receptors (CB1Rs),
which are expressed throughout the brain at high levels. Several
endogenous lipids, including anandamide (AEA) and
2-arachidonylglycerol (2-AG), have been identified as CB1R li-
gands (Devane et al., 1992; Di Marzo et al., 1994; Stella et al.,
1997). The synthesis of endocannabinoids is triggered by cyto-
plasmic Ca2. Endocannabinoids rapidly released from neurons
after depolarization mediate some forms of activity-dependent
short- and long-term presynaptic modulation of synaptic trans-
mission. These include depolarization-induced suppression of
inhibition, depolarization-induced suppression of excitation
(Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001; Wilson
and Nicoll, 2001, 2002; Diana et al., 2002) as well as long-term
depression of inhibitory synapses, which selectively “prime”
nearby excitatory synapses, facilitating subsequent induction of
long-term potentiation (Chevaleyre and Castillo, 2004). In par-
ticular, in the hippocampus, cannabinoids acting presynaptically
modulate both glutamatergic andGABAergic neurotransmission
(Misner and Sullivan, 1999; Hajos et al., 2000; Hoffman and Lu-
pica, 2000).
CB1R activation accounts for most of the central effects of can-
nabimimetic drugs. Nevertheless, although most of the behavioral
effects of cannabinoids are absent in CB1R-deficientmice, cannabi-
noids (in particular, AEA) still induce catalepsy and analgesia and
decrease spontaneous activity in these mice (Di Marzo et al., 1994;
Baskfield et al., 2004). Furthermore, inmice, the typical cannabimi-
metic effectsofAEAonspontaneousactivity, body temperature, and
pain perception are not reversed by treatmentwith the selectiveCB1
receptor antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4-
dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR141716A)
(Adamset al., 1998).Thesedata indicate theexistenceof functionally
important targets for brain cannabinoid signaling in addition to
CB1Rs.
Local alignment of amino acid sequences of cannabinoid re-
ceptors and glycine receptor (GlyR) subunits revealed that GlyRs
contain few fragments that display a high level of homology with
the regions within CB1R and CB2R, which are suggested to be
responsible for agonist binding (Mahmoudian, 1997; Tao et al.,
1999; Shim et al., 2003) (supplemental Figs. S1–S4, available at
www.jneurosci.org as supplemental material). This prompted us
to study possible functional interaction between cannabinoid
agonists and GlyR.
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Materials andMethods
Materials.All of the chemicals for intracellular and extracellular solutions
were purchased from Sigma (St. Louis, MO). (R)-()-(2,3-dihydro-5-
methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-
yl)-1-naphthalenylmethanone (WIN 55,212-2), AEA, and 2-AG were
obtained from Tocris Cookson (Bristol, UK). Ginkgolides B and J were
kindly provided by Dr. S. Chatterjee (Dr. Willmar Schwabe Group,
Karlsruhe, Germany).
Cell preparation.Wistar rats (12–17 d of age) were decapitated under
ether anesthesia, and the hippocampus (or cerebellum)was removed and
cut into slices (300–500 m) in a solution containing the following (in
mM): 150 NaCl, 5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 1.1 MgCl2, and 10
glucose, pH 7.4. Then, the slices were incubated for 10 min (hippocam-
pal) and for 30 min (cerebellar) at 32°C with 0.5 mg/ml of protease (type
XXIII) fromAspergillus oryzae. Single pyramidal cells fromCA1 andCA3
stratum pyramidale layers were isolated by vibrodissociation locally in
the stratum pyramidale, and Purkinje cells were isolated by successive
trituration of the small pieces of the Purkinje cell layer of the cerebellum
through several fire-polished pipetteswith opening diameters from0.5 to
0.1 mm. CA3 and CA1 hippocampal pyramidal and cerebellar Purkinje
neurons were identified by their characteristic form and partially pre-
served dendritic arborization.
After isolation, the cells were usually suitable for recordings for 2–4 h.
Throughout the entire procedure, the solutions with the slices were con-
tinuously saturated with 95% O2 and 5% CO2 gas mixture to maintain
pH 7.4. The tested substances were dissolved in DMSO to a stock con-
centration of 10 mM and kept frozen at 40°C in daily aliquots. The
substances were dissolved in external saline to their final concentration
immediately before the experiments.
Current recordings. Glycine-activated currents in isolated neurons
were induced by the step application of agonists in the “concentration-
clamp” mode (Krishtal et al., 1983), using the computerized Pharma-
Robot set-up (Pharma-Robot, Kiev, Ukraine). This equipment allows a
complete change of saline within 15 ms. Transmembrane currents were
recorded using a conventional patch-clamp technique in the whole-cell
configuration. Patch-clamp electrodes were pulled with a horizontal
puller (Sutter Instruments, Novato, CA) and had an internal tip diameter
between 1.4 and 1.8 m and a tip resistance between 2.5 and 5 M. The
intracellular solution contained the following (in mM): 70 Tris-PO4, 5
EGTA, 40 TEA-Cl (tetraethylammonium chloride), 30 Tris-Cl, 5 Mg-
ATP, and 0.5GTP, pH 7.2. The composition of extracellular solutionwas
as follows (in mM): 130 NaCl, 3 CaCl2, 5 KCl, 2 MgCl2, 10 HEPES–
NaOH, and 0.1 M TTX, pH 7.4. Recording of the currents was per-
formed using patch-clamp amplifiers (Dagan, Minneapolis, MN). To
avoid activation of the GABAA receptor (GABAAR) by glycine, the
GABAAR antagonist bicuculline (10 M) was routinely added to all ex-
tracellular solutions. Transmembrane currents were filtered at 3 kHz,
stored, and analyzed with an IBM-PC computer (IBM Corporation,
White Plains, NY) using homemade software. Glycine responses were
recorded with a 3 min interval. All experiments were performed at room
temperature (19–24°C).
Hippocampal slice experiments.During preincubation, the slices (300–
400 m thick) obtained from 17- to 19-d-old rats were kept fully sub-
merged in HCO3-buffered artificial CSF (ACSF) as follows (in mM): 135
NaCl, 5 KCl, 26 NaHCO3, 1.5 CaCl2, 1.5 MgCl2, and 20 glucose, pH 7.4,
equilibrated with 95%O2/5%CO2. The experiments were conducted in
the same solution, containing 2 mM CaCl2 and 1 mM MgCl2 at 32–34°C.
The nominallyHCO3-freeACSFwas saturatedwith 100%O2, and 26mM
NaHCO3 was replaced with HEPES acid, and pH was titrated to 7.4 with
NaOH.
Field potentials were recorded in the stratum radiatum using a tung-
sten electrode. To stimulate the Schaffer collateral–commissural path-
way, a bipolar Ni/Cr electrode was positioned on the surface of the slice.
The current intensity of test stimuli (25–50 A) was set to produce field
potentials of half-maximal amplitude. Current pulses were delivered
through the isolated stimulator HG 203 (Hi-Med, London, UK) at
0.066–0.2 Hz.
The care and use of animals for all experiments followed the guidelines
and protocols approved by our institutional Animal Care and Use Com-
mittee (protocol number no2/0204).
Data analysis. The effect of the substance was measured as the mean
ratio I/ICTRL, where I is the amplitude of the current under the action of
the substance, and ICTRL is the amplitude of the current in control saline.
The data were fitted using the Hill equation I/ICTRL 1 1/[1 (IC50/
[S])nH], where [S] is the concentration of the substance, IC50 is the half-
inhibition concentration of the substance, and nH is the Hill coefficient.
The IGly desensitization and deactivation kinetics (after 4-s-long pulses)
were fitted with monoexponential function. Exponential curve fitting was
performed using the simplest algorithm least-squares routines, with single
exponential equations of the form y yoA1e
(x  xo)/ , where des is the
time constant of IGly desensitization, and deac is the time constant of IGly
deactivation. The onset kinetics of IGly was estimated as the 20–80% rise
time (ton).
Fourier transformations of 2-s-long epochs of epileptiform discharges
were performed using Origin v7.0 software (OriginLab, Northampton,
MA).
Data were statistically compared using Student’s t test at a significance
level of p 0.05. Data are expressed as mean SEM.
Results
Glycine-activated currents in isolated hippocampal neurons
Application of glycine to CA1 and CA3 pyramidal neurons iso-
lated from the hippocampus of neonatal rats (12–17 d of age) in
the presence of the GABAAR antagonist bicuculline elicited whole-
cell chloride currents in line with previous studies (Krishtal et al.,
1988; Shirasaki et al., 1991;ChattipakornandMcMahon, 2002).The
amplitude, onset, and desensitization kinetics of glycine-activated
currents (IGly) were dependent on glycine concentration (Fig. 1a).
The EC50 value of glycine was 91 5 M, n 4, with a Hill coeffi-
cient of 2.2 0.2, which corresponds well with the values reported
Figure 1. a, Agonist concentration dependence of glycine-induced current (IGly). Left, Fam-
ily of IGly representative traces at increasing Gly concentration ranging from 20 to 300M. IGly
was recorded in a CA3 hippocampal neuron by conventional whole-cell techniques. Responses
were evoked by 4 s application of Gly (indicated here and in subsequent figures by gray bars
above traces) at a holding potential of100mV in the presence of 10M bicuculline. Middle,
The same tracesnormalized to thepeakamplitude. Right,Normalizedaveraged concentration–
response curve of IGly (n 4). b, Current–voltage relationship of IGly. Left, The family of repre-
sentative traces of current induced by 100M Gly at various holding potentials from100 to
20mVwith a 20mV step. Middle, Traces obtained at100 and20mV are superimposed
and normalized. Right, I–V of peak IGly, measured with 100M Gly.
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for acutely isolated cells from the hypothalamus (90 M) (Akaike
and Kaneda, 1989) or acutely isolated hippocampal neurons (69
M) (Kondratskaya et al., 2002). The reversal potential of IGly in our
experimental conditions was between 35 and 25 mV, with an
average value of28.15 2.2 mV (Fig. 1b) (n 4). IGly was com-
pletely andreversiblyblockedbyspecificGlyRblockers strychnine (1
M) and gingkolide B (10 M) (data not shown). These results and
the following data were obtained from CA3 pyramidal neurons;
however, qualitatively similar resultswere obtained inCA1neurons.
Modulation of glycine-activated currents by endogenous
cannabinoids in isolated hippocampal neurons
Both endogenous cannabinoids, 2-AG and AEA, at physiological
concentrations (0.2–2 M) strongly inhibited the peak IGly (Fig.
2a,b). I/ICTRL(*100%) values were 40  7% ( p  0.02; n  4)
with 1 M 2-AG and 20 7% ( p 0.02; n 4) with 1 M AEA.
Meanwhile, the IGly onset and desensitization were accelerated in
the presence of both endocannabinoids (Fig. 2). For example, the
time constant of IGly desensitization (des) decreased to 55 6%
( p 0.001; n 4) of control in the presence of 2-AG and to 40
15% ( p 0.02; n 4) in the presence of AEA. Figure 2 illustrates
the averaged ratios of IGly peak, des, and ton values in the presence
of 2-AG (Fig. 2c) and AEA (Fig. 2d) to control. The effects of
cannabinoids were concentration dependent (Fig. 2). The peak
amplitude, rise time, and des of IGly slowly and partially recov-
ered after washout of both drugs. No changes of the holding
current were observed in the presence of cannabinoids.
Endogenous cannabinoids significantly reduced peak and des
of IGly at all tested holding potentials.However, the changes in the
decay kinetics, induced by 2-AG, were more pronounced at pos-
itive membrane potentials (Fig. 3b,f). At20 mV, des decreased
to 31 9% in the presence of 2-AG compared with 55 6% at
100 mV ( p 0.02; n 4). In contrast, the effects of endocan-
nabinoids on the IGly onset did not display voltage dependence
(Fig. 3c,g).
The current decay after removal of Gly represents transitions
from active ligand-bound receptor states to inactive unbound
states, including channel closure and glycine dissociation. In ad-
dition, desensitized receptors may reopen before agonist dissoci-
ation, prolonging deactivation (Jones andWestbrook, 1995). The
fact that endocannabinoids accelerated the IGly desensitization
suggested the possibility that IGly desensitization anddeactivation
are coupled. Indeed, acceleration of IGly desensitization by 2-AG
was accompanied by a significant slowdown of IGly deactivation
(Fig. 3d,h). At 100 mV, the deactivation time constant (deac)
increased to 300 65% ( p 0.01; n 3).
Effects ofWIN 55,212-2 on glycine-activated currents
In contrast to endocannabinoids, the synthetic cannabinoid ag-
onist WIN 55,212-2 (1 M) barely affected the IGly peak ampli-
tude (IWIN/ICTRL was 107 2%; n 8). However, it significantly
and reversibly accelerated the desensitization as well as onset of
IGly, in a manner similar to 2-AG and AEA. The desensitization
time constant, des, decreased to 59 4% ( p 0.0001; n 11) of
control in the presence of WIN 55,212-2, and ton decreased to
58 5% of control ( p 0.02; n 11).
The WIN 55,212-2-induced acceleration of desensitization
and rise time of IGly exhibited clear concentration dependence
(Fig. 4). It is noteworthy that WIN 55,212-2 at higher concentra-
tion induced weak inhibition of the peak currents (at 5M, IWIN/
ICTRL was 65 5%; p 0.02; n 5).
As in the case of endocannabinoids, prominent voltage de-
pendence of the IGly desensitization observed in control condi-
tions was practically eliminated in the presence ofWIN 55,212-2.
This corresponds to a much more pronounced effect of WIN
55,212-2 on the desensitization kinetics at depolarized potentials
(Fig. 4). Indeed, the decrease of des induced by application of
WIN 55,212-2 was 35 5% at20mV compared with 59 4%
at 100 mV ( p  0.02; n  4). However, in contrast to endo-
cannabinoids and despite the pronounced changes in the IGly
desensitization, no significant change of deactivation was ob-
served even with high concentrations of WIN 55,212-2 (data not
shown). Qualitatively similar effects of both endogenous and
synthetic cannabinoids on GlyRs were observed in isolated Pur-
kinje neurons (supplemental Fig. S5, available at www.jneurosci.
org as supplemental material).
Figure 2. Modulation of IGly by endogenous cannabinoids. a, b, Left, Representative traces
of IGly, induced by 100MGly, obtained in control and in the presence of 1M 2-AG (a) or 1M
AEA (b). Middle and right, Corresponding traces are superimposed and normalized. The aver-
aged numbers for changes of IGly peak, des, and 20–80% rise time (ton) induced by 2-AG (c)
and AEA (d). e–h, Concentration dependence of AEA effects on IGly. e, Left, Representative
traces obtainedat various concentrations ofAEA ranged from200nmto2M.Middle and right,
Corresponding traces are normalized and superimposed. Summary plots showing the effect of
increasingAEA concentrations on the amplitude (f ),des (g), and ton (h) of IGly are shown (Vh
100 mV; n 4). Data are plotted as a fraction of the maximal glycine current in control.
Lozovaya et al. •Modulation of Glycine Receptors by Cannabinoids J. Neurosci., August 17, 2005 • 25(33):7499–7506 • 7501
The action of cannabinoids on GlyRs is
not mediated by activation of CB1/CB3,
vanilloid receptors, or
G-protein activation
An important question is whether canna-
binoid receptors are involved in the mod-
ulation of GlyRs. Although CB2Rs are not
expressed in the brain (Munro et al.,
1993), CB1Rs are abundantly expressed in
the CA1 pyramidal layer of the hippocam-
pus (Tsou et al., 1998). In addition to
CB1R, a novel “vanilloid-like” CB3 recep-
tor, which shares sensitivity to both canna-
binoid and capsaicin receptor agonists, has
been demonstrated recently in the hip-
pocampus (Hajos et al., 2001). Further-
more, AEA is known as an agonist of va-
nilloid receptors, VR1 (Zygmunt et al.,
1999, 2000). To test whether cannabinoid
and/or vanilloid receptors are involved in
modulation of GlyRs, the effects of canna-
binoids were tested in the presence of the
CB1R antagonist SR141716A or the CB3R
antagonist capsazepine. Figure 5 shows
that the effects of 1 M 2-AG on IGly peak
amplitude, decay, and onset kinetics were
preserved in the presence of CB1 receptor
antagonist SR141716A (Fig. 5a,e). No sig-
nificant differences in 2-AG or AEA-
induced effects on IGly desensitization and
onset were observed in the presence of
capsazepine (Fig. 5c–f).
To determine whether G-proteins me-
diate the actions of cannabinoids on
GlyRs, the G-protein inhibitor GDPS
was applied to the cells via the pipette so-
lution. After 30 min of GDPS pretreat-
ment, decay kinetics and rise time were ac-
celerated by 2-AG (1 M) to nearly the
same extent as in the control [50  3%
compared with 55 6% in control (n 3;
p 0.2) for des; 68.5 3%comparedwith
56 5% in control (Fig. 5b,e) (n 3; p
0.4) for ton]. Inhibition of IGly peak ampli-
tude was also not significantly different
from control numbers (52  2% com-
pared with 40 7% in control; n 3; p
0.2). Altogether, these data are consistent
with a direct action of cannabinoids on
GlyRs. In addition, the mapping studies in
rat brain showed that CB1Rs are mainly
localized to axons and nerve terminals and
are essentially absent on the neuronal
soma or dendrites (Tsou et al., 1998).
GlyR-driven seizure-like rhythmic
activity in hippocampal slices
The function of GlyRs in the hippocampus
is not clear. It is possible that these recep-
tors mediate neuronal function in a man-
ner similar to GABAARs. Numerous re-
ports indicate that GABAARs and GlyRs,
principal inhibitory receptors, when in-
Figure3. Voltagedependence of the IGlymodulation by 2-AG.a, Representative traces obtained in control condition and in the
presence of 1M 2-AG at holding potentials of100 and20mV. b, c, Corresponding traces normalized and superimposed. d,
Deactivation of IGly before and after preapplicationwith 2-AG. e–h, Statistics for the 2-AG effects on peak amplitude (e),des (f ),
ton (g), and deac (h) obtained at holding potentials of100 and20 mV.
Figure 4. Modulation of glycine-activated currents byWIN 55,212-2. a, Left, Traces of IGly induced by 100M Gly obtained in
control, in the presence of WIN 55,212-2 (1M), and after washout of drug (gray line) (Vh100 mV). Middle and right, The
same traces are superimposedandnormalized.b, Statistics of theeffects ofWIN55,212-2on theamplitude,des , and ton (n11)
of IGly. c– e, Concentration dependence of theWIN 55,212-2 effects on IGly kinetics. c, IGly traces recorded at various concentration
of WIN 55,212-2 ranged from 100 nM to 2Mmeasured in the same cell are normalized and superimposed. d, e, Summary plots
showing the effect of increasing the WIN 55,212-2 concentrations on des (d) and ton (e) measured at Vh100 mV (n 4).
Data areplottedas a fractionof themaximal glycine current in control. f–h, Voltagedependenceof the IGlymodulationby theWIN
55,212-2. f, Left, IGly representative traces obtained in control condition and in the presence of 1M WIN 55,212-2 at holding
potentials of100mV and20mV.Middle and right, The same traces are superimposed and normalized. Statistics for theWIN
55,212-2 effects on des (g) and ton (h) at holding voltages of100 and20 mV.
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tensely activated, excite rather than inhibit neurons (Alger and
Nicoll, 1979; Staley et al., 1995; Kaila et al., 1997; Taira et al., 1997;
Backus et al., 1998). It has been shown that excitatory GABAergic
transmission seems to play an active functional role in the gener-
ation of seizure-like rhythmic activity in the hippocampus
(Grover et al., 1993; Staley et al., 1995). We hypothesized that in
conditions of intense activation, GlyRs could also participate in
processes of synchronization of neuronal activity. To address the
functional implication of the direct action of cannabinoids on
GlyRs in the hippocampus, we tested the possibility that GlyRs
are involved in seizure-like activity induced by high-frequency
stimulation in the presence of bicuculline
and, if so, whether they are then modu-
lated by application of cannabinoids.
CA1 field network activity was induced
by repetitive stimulation with short bursts
of high-frequency stimulation (seven
stimuli at 50 Hz) applied to the Schaffer
collateral–commissural pathway with a 4
min interval in the presence of bicuculline
(20–40 M) (Fig. 6). This type of stimula-
tion protocol imitates natural patterns of
activity (Ranck, 1973). Seizure-like events
lasted for 1–4 s after burst stimulation and
can be classified as intermediate ictal activ-
ity (500 ms, interictal; 4 s, ictal)
(Traub et al., 1996). Experiments in which
the CA3 zone was surgically cut revealed
that this type of activity originated in the
CA3 zone, being completely eliminated in
minislices (Fig. 6a). Seizure-like activity
was completely blocked by antagonists of
excitatory transmission, 2,3-dihydroxy-6-
nitro-7-sulfonyl-benzo[f]quinoxaline-7-
sulfonamide (20 M) or D-AP-5 (50 M;
n 5). Our experiments revealed that sei-
zure-like activity was disrupted by strych-
nine (5–10 M) (Fig. 6b) and selective
GlyR antagonists ginkgolide B (10–20M)
and ginkgolide J (50–70 M) (data not
shown). Correspondingly, the power of
hippocampal epileptiform activity de-
creased in the presence of antagonists (Fig.
6e,h).
It has been shown that the GABAAR-
mediated excitatory response is a result of
an asymmetric, activity-dependent col-
lapse of the opposing electrochemical gra-
dients of two anions (Cl and HCO3) that
permeate aGABAAR channel (Bormann et
al., 1987; Kaila and Voipio, 1987).We pre-
sumed that depolarizing, GlyR-activated,
HCO3-carried currents, as in the case of
GABAARs (Bormann et al., 1987; Staley et
al., 1995; Kaila et al., 1997), could be in-
volved in the generation of strychnine-
sensitive seizure-like activity. To prove
this hypothesis, we conducted experi-
ments in nominally CO2/HCO3-free me-
dium. After 20–30 min of perfusion with
HEPES-buffered solution saturated with
100%O2, seizure-like activity was strongly
attenuated (Fig. 6c,f,i). This observation is
consistent with a key role for HCO3 in the generation of the
depolarizing response.
Modulation of hippocampal GlyR-driven epileptiform
activity by cannabinoids
In line with strong inhibitory action of cannabinoids on IGly ob-
served in isolated neurons, GlyR-driven epileptiform activity was
also significantly impaired by high concentrations of AEA (10–20
M) in control conditions and in the presence of CB1 receptor
antagonist SR141716A (Fig. 6d). The maximal power of hip-
pocampal epileptiform activity (frequency,10Hz) decreased in
Figure 5. CB1/CB3 receptors and G-proteins are not involved in themodulation of IGly by cannabinoids.a– c, Left, Traces of IGly
(100M) obtained in the control andwith 1M 2-AG in the presence of SR141716A (2M) (a), intracellularly preapplied GDPS
(2 mM) (b), and capsazepine (CPZ; 1M) (c). Vh100mV. Middle and right, The same traces are superimposed and normal-
ized. e, Statistics of the effects of 2-AG on the peak amplitude, des, and ton (n 4) of IGly in the presence of SR141716A,
capsazepine, and during intracellular perfusion with GDPS. IGly peak amplitude inhibition induced by 2-AG in the presence of
SR141716Awas469%comparedwith407%in control (n3;p0.5),whereas corresponding figures fordeswere55
4% in the presence of antagonist comparedwith 556%(n3;p0.8), and tonwas 549%comparedwith 565%(n
3; p 1). d, Left, Traces of IGly (100M) obtained in the control and with 1M AEA in the presence of 1M capsazepine (CPZ).
Middle and right, The same traces are superimposed andnormalized. f, Statistics of the effects of AEAon the peak amplitude,des,
and ton of IGly in thepresenceof CPZ. In thepresenceof CPZ, decay kinetics and rise timewereacceleratedbyAEA tonearly the same
extent as in the control: 42 2% comparedwith 40 15% in control (n 3; p 0.8) for des; 50 8% comparedwith 62
16% in control (n 3; p 0.7) for ton.
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the presence of AEA in control to 31 9%
(n 4) compared with 54 8% (n 4),
in the presence of SR141716A (Fig. 6g,j).
Concentrations of AEA used in this set of
experiments were higher than those in ex-
periments using isolated cells to overcome
the enzymatic attack of fatty acid amide
hydrolase, which breaks down anandam-
ide into arachidonic acid and ethanol-
amine (Hillard et al., 1995).
WIN 55,212–2 at a high concentration
(10 M), which produced significant inhi-
bition of IGly amplitude, attenuated
seizure-like activity in the hippocampus in
the same way as AEA (data not shown).
These results suggest the possibility of
modulation of the GlyR-mediated net-
work activity by cannabinoids.
Discussion
Here, we report that cannabinoids
strongly modulate gating of GlyR-
activated chloride channels in isolated hip-
pocampal pyramidal and Purkinje neu-
rons. Thus, in addition to the well known
retrograde mode of cannabinoid action
activating presynaptic CB1Rs (which im-
plies diffusion of a messenger from
postsynaptic elements backwards to the
presynaptic cell), the present results show
a novel, direct action of endocannabinoids
on GlyRs. These receptors can be located
in close proximity to the point of release of
cannabinoids from the postsynaptic cell
and may serve as a target for cannabinoid
signaling.
Glycinergic synapses are found inmany
CNS regions, including the spinal cord,
brainstem, and cerebellum (Jonas et al.,
1998; Chery and de Koninck, 1999;
O’Brien and Berger, 1999), where they
play a well established role in the process-
ing of motor and sensory information that
controls movement, vision, and audition
(Aprison, 1990; Moss and Smart, 2001).
Our results suggest that this transmission
can be directly modulated by endog-
enously released cannabinoids. The ma-
chineries necessary for both synaptic and
nonsynaptic GlyR-mediated transmission
have been reported to be present in the
hippocampus. In particular, synaptoneu-
rosomes obtained from adult rat hip-
pocampus contain glycine and release it by
both vesicular and nonvesicularmechanisms (Burger et al., 1991;
Engblom et al., 1996). Expression of  heteromeric GlyRs in the
developing hippocampus (Malosio et al., 1991; Chattipakorn and
McMahon, 2002; Kondratskaya et al., 2004) indicate the synaptic
location of GlyRs, because the  subunit is required for receptor
clustering (Kirsch et al., 1993; Meyer et al., 1995). Recent immu-
nocytochemical studies demonstrate both synaptic and nonsyn-
aptic expression of GlyRs in the hippocampus (Brackmann et al.,
2004). Finally, colocalization of glycine transporters andGlyRs in
the hippocampus (Jursky and Nelson, 1995) suggests the possi-
bility that extrasynaptic GlyRs could be activated by reverse up-
take of glycine. Few reports suggest the possibility that GlyRsmay
mediate the inhibitory effects of glycine in the hippocampus
(Cherubini et al., 1981; Seiler and Sarhan, 1984; Chattipakorn
and McMahon, 2003). Nevertheless, to date, the physiological
role for and conditions under which GlyRs are activated in the
hippocampus were unknown.
Our data show that seizure-like activity induced by repetitive
Figure6. GlyR-driven seizure-like rhythmic activities inhippocampal slices attenuatedbyAEA.a, Seizure-like activity recorded
from CA1 and CA3 stratum radiatum in response to stimulation (S) of Schaffer collateral– commissural pathway with high-
frequency short trains of stimuli (7 stimuli; 50 Hz) applied every 4 min in the presence of 30M bicuculline. Slice events were
detected by using extracellular field potential recordings (R). Cutting the Schaffer collaterals abolishes discharges in the CA1 area,
indicating that excitatory inputs from the CA3 area are necessary for entraining CA1 to generate the epileptiform discharges.
Traces of epileptiform discharges in control and in the presence of strychnine (b) and AEA (20M) against the background of
SR141716A (1M) (d) are shown. c, Experiment demonstrating attenuation of epileptiform activity after 30 min of perfusion in
nominally CO2-free superfusionmedium. Note that control field potentials, evoked by single stimuli stimulation of Shaffer collat-
eral– commissural pathway (no bicuculline), did not change after changing of superfusion medium (inset). e–g, Corresponding
averaged Fourier transformations (4 epochs of 2 s recordings) of epileptiform activity. h–j, The normalized summarized Fourier
transformations of 2-s-long epochs of epileptiform discharges at-frequency bands in control and in the presence of strychnine
(5M; n 5) (h), in CO2-free medium (n 3) (i), and in the presence of AEA and SR141716A (n 4) (j).
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high-frequency short-burst stimulation in the presence of bicu-
culline in the CA1 zone of hippocampal slices revealed paradoxal
sensitivity to GlyR antagonists, indicating that GlyRs drive this
activity. We suggest that GlyRergic excitation can participate in
the expression of seizure-like rhythmic synchronization in the
hippocampus. This hypothesis was supported by our finding that
strychnine-sensitive slice events were eliminated in CO2/HCO3
nominally freemedium, indicating that HCO3 ions are themajor
driven anions for seizure expression. Therefore, it is possible to
suggest that inhibition of GlyRs induced by cannabinoids could
result either in a decrease in the amount of synaptic GlyR-
mediated excitatory drive necessary for synchronized behavior
or, if extrasynaptic GlyRs are the main players, in the decrease of
tonic excitability and shift of seizure threshold. Thus, in either the
extrasynaptic or synaptic scenario, inhibition of GlyRs would
lead to a disruption of network activity. Indeed, GlyR antagonist-
sensitive epileptiform activity was depressed by AEA. The latter
finding is in agreement with the previous observation that both
WIN 55,212-2 and AEA inhibited interictal activity induced by
low-Mg2/high-Kmedium recorded in the CA1 stratum pyra-
midale of the hippocampus (Ameri et al., 1999).
Acceleration of desensitization of IGly by cannabinoids is of
particular interest. Both homo-oligomeric and hetero-
oligomeric GlyRs display slow desensitization with a slow recov-
ery. This suggests that the time course and the amplitude of gly-
cinergic miniature IPSCs will only be slightly affected by
desensitization. Desensitization of homomeric 1 GlyR has been
shown by others to be more prominent with increased receptor
density (Legendre et al., 2002) and with phosphorylation of the
receptor (Gentet and Clements, 2002). In both of these studies,
acceleration of desensitization was reported to prolong the cur-
rent relaxation time course. Slow desensitization of GlyRs cannot
play a significant role after release of a single vesicle. However, it
might contribute to glycinergic synaptic efficacy when a long-
lasting (seconds-range) depolarization of the postsynaptic mem-
brane is coupled with high-frequency cell activity (Legendre,
1998).Moreover, the prolonged deactivation phase of glycinergic
events should act to reinforce the efficacy of inhibition.
Slowdown of IGly deactivation could also have important con-
sequences for inhibitory network behavior, because the rate of
decay of synaptic responses can significantly alter firing fre-
quency and the ability of the network to synchronize (Wang and
Rinzel, 1992; Wang and Buzsaki, 1996).
The time course of synaptic conductance is an important de-
terminant of the temporal precision of information processing
within a neuronal network. Synaptic integration depends on the
duration of the EPSPs, because this determines both the time
windowwithin which they summate to reach spike threshold and
the temporal precision of spike generation (Fricker and Miles,
2000; Galarreta and Hestrin, 2001) and the efficacy of informa-
tion transfer (London et al., 2002). This is important because fast
EPSPs allow neurons to behave as coincidence detectors, whereas
neurons with slow EPSPs may behave as temporal integrators
(Geiger et al., 1997; Trussell, 1997; Taschenberger and von Gers-
dorff, 2000). In particular, interaction between excitatory and
inhibitory action provides a mechanism for processing auditory
temporal information. Blocking GABAergic or glycinergic inhi-
bition can eliminate duration tuning, suggesting that the neural
code for sound duration is the result of convergence of excitatory
and inhibitory inputs (Casseday et al., 2000). The matching of
excitatory transmission in the calyx of Held by a powerful, preci-
sion glycinergic inhibitory system suggests that the relay function
of themedial nucleus of the trapezoid body of ratsmay be rapidly
modified during sound localization (Awatramani et al., 2004).
In the case of the “extrasynaptic scenario,” prolonged depo-
larization induced by tonic activation of extrasynaptic GlyRs
would be decreased in the presence of cannabinoids, resulting in
decreased neuronal excitability. Inhibition of tonic GlyR-
mediated conductance can lead to attenuation ofmembrane con-
ductance and slowdown of the EPSC decay that is crucial for
temporal summation.
Altogether, our findings suggest a fundamental importance of
GlyR in hippocampal network activity and nominate GlyR as a
novel target for endocannabinoid signaling.
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